Results 151 to 160 of about 10,632 (179)

Clinical Pharmacokinetics of Darunavir

Clinical Pharmacokinetics, 2012
Keikawus Arasteh, Arasteh Keikawus
exaly  

Darunavir, a conceptually new HIV-1 protease inhibitor for the treatment of drug-resistant HIV

Bioorganic and Medicinal Chemistry, 2007
Hiroaki Mitsuya, Arun Ghosh
exaly  

POLYMORPHS OF DARUNAVIR

2011
PARTHASARADHI REDDY BANDI, RATHNAKAR REDDY KURA, MURALIDHARA REDDY DASARI, RAJI REDDY RAPOLU, SUBASH CHANDER REDDY KESIREDDY, VAMSI KRISHAN BANDI   +5 more
openaire   +4 more sources

CRYSTALLINE DARUNAVIR

2013
VELLANKI SIVA RAMA PRASAD, SAHU ARABINDA, PHADHURI NAVEEN KUMAR, KILARU RAVINDRABABU   +3 more
openaire   +2 more sources

Pharmacokinetics, Efficacy, and Safety of Darunavir/Ritonavir 800/100 mg Once-Daily in Treatment-Naïve and -Experienced Patients

HIV Clinical Trials, 2008
Marta Boffito, Andrew M Hill
exaly  

Darunavir

2013
openaire   +1 more source

Darunavir/ritonavir

Reactions Weekly, 2018
openaire   +1 more source

Darunavir: A second-generation protease inhibitor

American Journal of Health-System Pharmacy, 2007
Scott R Penzak, Penzak Scott R
exaly  

Darunavir/tenofovir

Reactions Weekly, 2018
openaire   +1 more source

Long-term efficacy of darunavir/ritonavir monotherapy in patients with HIV-1 viral suppression: week 96 results from the MONOI ANRS 136 study

Journal of Antimicrobial Chemotherapy, 2012
Philippe Flandre, Lise Cuzin, André Cabie   +2 more
exaly